Treatment and prevention of purulent-inflammatory and enteral diseases caused by bacteria R. vulgaris and P. mirabilis as part of complex therapy:
- Diseases of the ear, throat, nose, respiratory tract and lungs (inflammation of the sinuses of the nose, middle ear, sore throat, pharyngitis, laryngitis, tracheitis, bronchitis, pneumonia, pleurisy);
- surgical infections (suppuration of wounds, burns, abscess, phlegmon, furuncles, carbuncles, hydradenitis, panaritium, paraproctitis, mastitis, bursitis, osteomyelitis);
- urogenital infections (urethritis, cystitis, pyelonephritis, colpitis, endometritis, salpingoophoritis);
- enteral infections (gastroenterocolitis, cholecystitis), intestinal dysbiosis;
- generalized septic diseases;
- purulent-inflammatory diseases of newborns (omphalitis, pyoderma, conjunctivitis, gastroenterocolitis, sepsis, etc.);
- Other diseases caused by bacteria Proteus.
With the preventive purpose, the drug is used for the treatment of postoperative and freshly infected wounds, as well as for the prevention of nosocomial infections due to epidemic indications.
An important condition for effective phage therapy is the preliminary determination of the pathogenicity of the pathogen.